Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.77% 6.55 6.50 6.60 6.55 6.50 6.50 2,109,874 12:57:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 6.1 -0.0 0.1 81.9 30

Byotrol PLC Exercise of Options & Total Voting Rights

21/01/2021 10:30am

UK Regulatory (RNS & others)

Byotrol (LSE:BYOT)
Historical Stock Chart

From Nov 2020 to May 2021

Click Here for more Byotrol Charts.


RNS Number : 4631M

Byotrol PLC

21 January 2021

Byotrol Plc

("Byotrol" or the "Group")

Exercise of Options and Total Voting Rights

Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that it has allotted a total of 3,381,000 new ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of options by certain employees, all of whom are below Board level.

Application has been made for the 3,381,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 26 January 2021.

After Admission, the total number of Ordinary Shares in issue will be 446,530,405 and the total number of voting rights will therefore be 446,530,405. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information contact:

 Byotrol Plc 
 David Traynor, Chief Executive                            +44 (0)1925 742 000 
 Nic Hellyer, Chief Financial Officer 
 finnCap Limited (Nominated Adviser and 
  Broker)                                                  +44 (0)20 7220 0500 
 Geoff Nash/Kate Bannatyne - Corporate Finance 
 Richard Chambers - ECM 
 Flagstaff Strategic and Investor Communications           +44 (0)20 7129 1474 
 Tim Thompson/Andrea Seymour/Fergus Mellon 

Notes to editors

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

January 21, 2021 05:30 ET (10:30 GMT)

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210515 18:01:13